Will the Phase 2 trial "Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder" reach primary completion on or before Apr 30, 2028?

Resolves Yes if ClinicalTrials.gov record NCT07523633 (Anders Fink-Jensen, MD, DMSci) shows an actual primary completion date on or before Apr 30, 2028. Registered date at generation: Apr 30, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Apr 30, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.